Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma

J Clin Oncol. 2021 Mar 10;39(8):943-944. doi: 10.1200/JCO.20.03213. Epub 2021 Jan 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Melanoma* / drug therapy
  • Skin Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab